Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
González-Blanch, C.
Perez-Iglesias, R.
Pardo-García, G.
Rodríguez-Sánchez, J. M.
Martínez-García, O.
Vázquez-Barquero, J. L.
and
Crespo-Facorro, B.
2010.
Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia.
Psychological Medicine,
Vol. 40,
Issue. 6,
p.
935.
González-Blanch, César
Rodríguez-Sánchez, José Manuel
Pérez-Iglesias, Rocío
Pardo-García, Gema
Martínez-García, Obdulia
Vázquez-Barquero, José Luis
and
Crespo-Facorro, Benedicto
2010.
First-episode schizophrenia patients neuropsychologically within the normal limits: Evidence of deterioration in speed of processing.
Schizophrenia Research,
Vol. 119,
Issue. 1-3,
p.
18.
van Veelen, Nicoletta M.J.
Grootens, Koen. P.
Peuskens, J.
Sabbe, B.G.C.
Salden, Miriam E.
Verkes, R.J.
Kahn, René S.
and
Sitskoorn, Margriet M.
2010.
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.
Schizophrenia Research,
Vol. 120,
Issue. 1-3,
p.
191.
Boonstra, Geartsje
Cahn, Wiepke
Schnack, Hugo G.
Hulshoff Pol, Hilleke E.
Minderhoud, Tanca C.
Kahn, René S.
and
van Haren, Neeltje E.M.
2011.
Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change.
Schizophrenia Research,
Vol. 132,
Issue. 1,
p.
84.
González-Blanch, César
Priede, Amador
Rodríguez-Sánchez, José Manuel
Perez-Iglesias, Rocío
Vázquez-Barquero, José Luis
and
Crespo-Facorro, Benedicto
2012.
Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible?.
Comprehensive Psychiatry,
Vol. 53,
Issue. 6,
p.
701.
Meltzer, Herbert Y.
Rajagopal, Lakshmi
Huang, Mei
Oyamada, Yoshihiro
Kwon, Sunoh
and
Horiguchi, Masakuni
2013.
Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
International Journal of Neuropsychopharmacology,
Vol. 16,
Issue. 10,
p.
2181.
Barajas, Ana
Usall, Judith
Baños, Iris
Dolz, Montserrat
Villalta-Gil, Victoria
Vilaplana, Miriam
Autonell, Jaume
Sánchez, Bernardo
Cervilla, Jorge A.
Foix, Alexandrina
Obiols, Jordi E.
Haro, Josep Maria
and
Ochoa, Susana
2013.
Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis.
Schizophrenia Research,
Vol. 151,
Issue. 1-3,
p.
252.
Ayesa-Arriola, Rosa
Pérez-Iglesias, Rocío
Rodríguez-Sánchez, José Manuel
Pardo-García, Gema
Tabares-Seisdedos, Rafael
Ayuso-Mateos, Jose L.
Vázquez-Barquero, Jose L.
and
Crespo-Facorro, Benedicto
2013.
Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 43,
Issue. ,
p.
23.
González-Blanch, César
Álvarez-Jiménez, Mario
Ayesa-Arriola, Rosa
Martínez-García, Obdulia
Pardo-García, Gema
Balanzá-Martínez, Vicent
Suárez-Pinilla, Paula
and
Crespo-Facorro, Benedicto
2014.
Differential associations of cognitive insight components with pretreatment characteristics in first-episode psychosis.
Psychiatry Research,
Vol. 215,
Issue. 2,
p.
308.
Register-Brown, Kelly
and
Hong, L. Elliot
2014.
Reliability and validity of methods for measuring the duration of untreated psychosis: A quantitative review and meta-analysis.
Schizophrenia Research,
Vol. 160,
Issue. 1-3,
p.
20.
Venero, César
2015.
Cognitive Enhancement.
p.
233.
Bergh, Sara
Hjorthøj, Carsten
Sørensen, Holger J.
Fagerlund, Birgitte
Austin, Stephen
Secher, Rikke Gry
Jepsen, Jens Richardt
and
Nordentoft, Merete
2016.
Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10 years after baseline: The OPUS study.
Schizophrenia Research,
Vol. 175,
Issue. 1-3,
p.
57.
Allott, K.
Fraguas, D.
Bartholomeusz, C. F.
Díaz-Caneja, C. M.
Wannan, C.
Parrish, E. M.
Amminger, G. P.
Pantelis, C.
Arango, C.
McGorry, P. D.
and
Rapado-Castro, M.
2018.
Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis.
Psychological Medicine,
Vol. 48,
Issue. 10,
p.
1592.
Dannevang, Anders L.
Randers, Lasse
Gondan, Matthias
Krakauer, Kristine
Nordholm, Dorte
and
Nordentoft, Merete
2018.
Premorbid adjustment in individuals at ultra‐high risk for developing psychosis: a case–control study.
Early Intervention in Psychiatry,
Vol. 12,
Issue. 5,
p.
839.
Stefanatou, Pentagiotissa
Karatosidi, Chrysovalado-Sofia
Tsompanaki, Evgenia
Kattoulas, Emmanouil
Stefanis, Nicholas C.
and
Smyrnis, Nikolaos
2018.
Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
Psychiatry Research,
Vol. 267,
Issue. ,
p.
249.
Bucci, P.
Galderisi, S.
Mucci, A.
Rossi, A.
Rocca, P.
Bertolino, A.
Aguglia, E.
Amore, M.
Andriola, I.
Bellomo, A.
Biondi, M.
Cuomo, A.
dell'Osso, L.
Favaro, A.
Gambi, F.
Giordano, G. M.
Girardi, P.
Marchesi, C.
Monteleone, P.
Montemagni, C.
Niolu, C.
Oldani, L.
Pacitti, F.
Pinna, F.
Roncone, R.
Vita, A.
Zeppegno, P.
and
Maj, M.
2018.
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition.
Acta Psychiatrica Scandinavica,
Vol. 138,
Issue. 3,
p.
253.
García-Laredo, Eduardo
2018.
Psychosis - Biopsychosocial and Relational Perspectives.
Bora, Emre
Yalincetin, Berna
Akdede, Berna Binnur
and
Alptekin, Koksal
2018.
Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis.
Schizophrenia Research,
Vol. 193,
Issue. ,
p.
3.
O’Keeffe, Donal
Hannigan, Ailish
Doyle, Roisin
Kinsella, Anthony
Sheridan, Ann
Kelly, Aine
Madigan, Kevin
Lawlor, Elizabeth
and
Clarke, Mary
2019.
The iHOPE-20 study: Relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis.
Australian & New Zealand Journal of Psychiatry,
Vol. 53,
Issue. 11,
p.
1080.
Prat, Gemma
Marquez-Arrico, Julia E.
Río-Martínez, Laura
Navarro, José Francisco
and
Adan, Ana
2021.
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 110,
Issue. ,
p.
110310.